Drugs with this side effect
- 1,25(OH)2D3
- 4-AP: 7%
- 5-ASA: postmarketing, 1% - 20%
- 5-aza-2'-deoxycytidine: 15.2%
- 5-azacytidine: 20.7% - 29.1%
- 5-fluorocytosine
- ALX 111
- BCNU: 1% - 22%
- BPTI
- Benicar-HCT
- CAS 76095-16-4: 1.1% - 1.6%
- CAS 76420-72-9
- CGP 19835A: very common, 13%
- Cancidas: 0% - 6.7%
- Cantril
- Carfilzomib: 0.19% - 13.9%
- Colimycin M
- DFMO: 0% - 1%
- Enfuvirtide: 0.6% - 2.7%
- FAMP: 9% - 65%
- FTY720: common, 2.59% - 3%
- FdUrd
- Fe(III: 0% - 7%
- Forteo: 8.7%
- Gd-DTPA
- Ge-132: 10%
- Glat copolymer
- Goserelin: 5% - 13%
- Histrelin
- Humalog: 7.41% - 8.14%
- ICI 182,780: postmarketing, 5.82% - 27%
- Implanon
- Insulin
- K779: postmarketing, 5% - 66%
- Kaluril
- L-Dmp
- LY146032: postmarketing, common, 5% - 5.2%
- Leuprorelin: 10%
- Lisinopril: postmarketing, uncommon, 1.3% - 7.1%
- Lovaza
- Lutalyse
- MDV3100
- MK-462
- Meropenem anhydrous
- Mersyndol
- N-carbamylglutamate
- N-methylscopolamine
- Nafarelin
- NovoLog
- Octreotide: 1-0%
- Oestrogen: 0.773% - 13.7%
- Optison
- PCI-32765
- PGE1
- PGE2
- Photofrin: 5% - 6%
- Photofrin II: uncommon
- Promacta
- Romidepsin: 7.84% - 77.1%
- SOM230: 6.25% - 15.9%
- SU5416
- Sativex
- Signifor: 6.25% - 15.9%
- Stalevo 50
- Supremon: 7.14% - 22%
- TPGS
- Triptorelin: 1.1%
- UDCA
- VACV: 0% - 43%
- Zyprexa Relprevv: common
- abacavir
- acamprosate: 5% - 7%
- acebutolol
- acipimox
- acyclovir: 1.2%
- adefovir: 13%
- adefovir dipivoxil: postmarketing, very common, 5% - 13%
- adenosine
- alendronate: postmarketing
- alfuzosin: common, 2.1%
- aliskiren
- allopurinol: postmarketing
- almotriptan: infrequent
- alprazolam: infrequent, frequent, 7.1% - 8.4%
- amantadine: common
- ambrisentan: postmarketing
- amiloride
- amiodarone
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine
- amphetamine
- amphotericin B: 10.8% - 13.1%
- amsacrine
- anagrelide: 23.1%
- anastrozole: 0.3% - 19%
- apomorphine
- apraclonidine: postmarketing
- aprepitant: 0.2% - 3.7%
- aripiprazole: 7% - 8%
- arsenic
- arsenic trioxide
- articaine
- atazanavir: uncommon
- atomoxetine: uncommon
- atorvastatin: 0% - 3.8%
- atovaquone: 8% - 31%
- atropine: rare
- avanafil
- axitinib: 3% - 21%
- azilsartan
- azithromycin: postmarketing
- aztreonam
- baclofen: common, 0% - 15%
- benazepril
- benazeprilat
- bendamustine: 0% - 8.5%
- bendrofluazide
- benzathine penicillin
- bepridil: 6.52% - 13.9%
- betaxolol: postmarketing, 0% - 7.1%
- bexarotene: 0% - 45.3%
- bicalutamide: postmarketing, common, 22%
- bicarbonate
- bimatoprost: common, 0.8% - 1.4%
- bisoprolol: postmarketing, common, 0.4% - 1.5%
- bleomycin hydrochloride
- boceprevir: very common, 16% - 18%
- bortezomib: 0% - 11%
- bosentan
- bosutinib
- brimonidine: common, 1.6%
- brinzolamide: postmarketing
- bromocriptine
- budesonide
- bumetanide: 0.2%
- bupivacaine: postmarketing
- buprenorphine: 4.85% - 15.6%
- bupropion: postmarketing, frequent, 1.6% - 4%
- buspirone: 2%
- busulfan: 51%
- butorphanol
- cabazitaxel: 2% - 5%
- cabergoline: 3.8% - 8.93%
- cabozantinib: 1% - 21%
- calcium: postmarketing
- canagliflozin
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 46%
- captopril
- carbamazepine: 8%
- carbidopa
- carboplatin: 8% - 11%
- carboprost
- carnitine: 8% - 12%
- carteolol
- carvedilol: 0.4% - 11%
- cefaclor: 1.36% - 3.33%
- cefadroxil
- cefazolin
- cefdinir
- cefditoren
- cefpodoxime
- ceftobiprole
- celecoxib
- celiprolol
- cerivastatin: 3.4%
- cetirizine: postmarketing
- cevimeline: 0.5%
- chloroquine
- chlorthalidone
- cidofovir: postmarketing, 43.5%
- cilazapril: 0.3% - 1.6%
- cilostazol
- cinacalcet: common, 7% - 17.2%
- ciprofloxacin: postmarketing
- cisplatin
- citalopram: postmarketing, infrequent, uncommon, 1% - 11.5%
- citric acid
- cladribine: very common, 6% - 9%
- clarithromycin: postmarketing, common
- clobazam
- clofarabine
- clomiphene citrate: postmarketing
- clomipramine: 2%
- clonidine
- clopidogrel
- clozapine: 1%
- cobicistat: uncommon
- codeine
- colesevelam: 3.59% - 4%
- colestimide: uncommon
- colestipol
- conjugated estrogens
- copolymer 1
- cyanocobalamin
- cyclizine
- cyclobenzaprine
- cyclophosphamide: postmarketing
- cyproterone
- cyproterone acetate
- cysteamine: common
- cytarabine: 5% - 53.6%
- dabigatran etexilate
- dabrafenib: very common, 0% - 17.6%
- dalteparin
- danazol
- dantrolene: 3.23% - 3.33%
- darifenacin: uncommon, 1.48% - 2.69%
- darunavir: 0% - 2.14%
- dasatinib: common, 1% - 6%
- degarelix
- delamanid
- delavirdine
- delta 9-THC
- deprenyl
- desflurane: postmarketing
- desipramine
- desmopressin: 0% - 2%
- desvenlafaxine: 1%
- diatrizoate
- diazepam: 4%
- diazoxide
- dichlorphenamide
- diclofenac: postmarketing, 0% - 2%
- dicyclomine: 7%
- didanosine: postmarketing
- diflunisal
- digoxin
- dihydroergotamine: 1%
- diltiazem: 0.6% - 6%
- dimercaprol
- dipyridamole: 0.3%
- disulfiram
- docetaxel: 1% - 43%
- dofetilide
- domperidone
- donepezil: frequent, 1% - 2%
- dorzolamide
- doxazosin: 1% - 6.9%
- doxepin: infrequent
- doxercalciferol
- doxorubicin: postmarketing, very common, 0% - 51.5%
- dronedarone
- duloxetine: frequent, 2% - 8%
- edrophonium
- efavirenz: postmarketing
- eletriptan: 4% - 10%
- eliglustat: 0% - 8.49%
- eltrombopag
- emedastine
- emtricitabine: postmarketing, common
- entacapone: 2%
- ephedrine
- eplerenone: uncommon
- eprosartan
- ergotamine
- eribulin: 10% - 54%
- erlotinib: 3.6%
- ertapenem
- eslicarbazepine
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: 11%
- estradiol: postmarketing, 0% - 7.87%
- etodolac
- etoposide: 3% - 39%
- etoposide phosphate
- etoricoxib
- everolimus: very common, 0% - 19%
- exemestane: 6%
- exenatide: 4% - 5%
- ezetimibe: postmarketing
- famotidine
- febuxostat
- felbamate: frequent
- felodipine
- fenofibrate: postmarketing, rare, uncommon, 0.533% - 2.94%
- fenofibric acid: postmarketing
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 38%
- ferumoxytol: postmarketing
- finasteride: 5.3% - 15.7%
- flecainide: 2% - 4.9%
- fluconazole: postmarketing, uncommon
- fludarabine: 9% - 65%
- fludrocortisone
- flumazenil
- flunisolide
- flunitrazepam: uncommon
- fluorescein: postmarketing
- fluoxetine: very common, 4.4% - 21.7%
- flurazepam
- flurbiprofen
- fluvastatin: postmarketing
- fluvoxamine: common, frequent, 2% - 28.8%
- formoterol
- fosaprepitant dimeglumine: 0.2% - 1.5%
- foscarnet
- fosfomycin: 0% - 1.1%
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: 0% - 3.9%
- frovatriptan: infrequent
- furosemide
- gabapentin: frequent, 4% - 41%
- gadobenate dimeglumine
- gadofosveset
- gadolinium: 1.53%
- gadopentetate
- gadoversetamide: 0.782% - 2.43%
- galantamine: frequent, 2.3%
- ganciclovir: 0.8%
- gatifloxacin
- gefitinib: common, 0% - 10.4%
- gemcitabine: common, very common
- gemifloxacin
- glibenclamide
- gliclazide: 2.2% - 2.6%
- glimepiride: 1.6% - 12%
- glipizide: 10.1%
- glucose
- glycopyrrolate: uncommon
- granisetron: 5% - 25%
- guanfacine: postmarketing, 1% - 5%
- halofantrine
- histamine
- hydrochlorothiazide
- hydroflumethiazide
- hydromorphone: 1.49% - 11%
- hydroxybutyrate: 3%
- hydroxychloroquine
- hydroxyurea
- ibandronate: 1.4% - 6.58%
- ibuprofen
- icodextrin
- ifosfamide
- imatinib: common, 0% - 74.9%
- imipramine: very rare
- imiquimod: uncommon, 0.2% - 0.8%
- indapamide: 1.7% - 4%
- indinavir: 2.1% - 7.7%
- insulin detemir
- iodide
- iopamidol
- iopromide
- ioxilan
- irbesartan: postmarketing, uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: 4.2% - 76%
- iron sucrose
- isomannide
- isoniazid
- isoproterenol
- isosorbide-5-mononitrate
- isradipine: 1.2%
- itraconazole
- ivabradine
- ivermectin
- ixabepilone: 4% - 56%
- ketoconazole
- ketorolac
- ketorolac tromethamine: postmarketing
- labetalol: 0% - 1%
- lacosamide: 2% - 4%
- lamivudine: postmarketing, 8% - 19%
- lamotrigine: 0% - 8.6%
- lanreotide
- lansoprazole: 1.1%
- lapatinib: very common, 0% - 11%
- leflunomide: postmarketing, common, 3% - 6%
- lenalidomide: common, 2.99% - 14.2%
- lercanidipine: rare, very common
- letrozole: 0.151% - 33.6%
- leucovorin
- leuprorelin acetate: 3% - 64.1%
- levetiracetam: 1.3% - 15%
- levobunolol
- levodopa/carbidopa
- levonorgestrel: 8% - 16.9%
- lidocaine
- linezolid
- lomefloxacin
- lomitapide
- lorazepam: infrequent, 4.2%
- lormetazepam
- losartan: 3.8% - 14%
- lovastatin: postmarketing, 1.2% - 1.7%
- loxapine
- lubiprostone: postmarketing
- malvidin
- maprotiline
- maraviroc
- mecamylamine
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing, 5%
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 2% - 6%
- megestrol acetate
- melatonin
- memantine
- meperidine
- mepivacaine
- meprobamate
- meropenem
- mesna
- metaproterenol: 0.2% - 1%
- metformin: 9.2%
- methadone
- methotrexate
- methyclothiazide
- methyldopa
- methylene diphosphonate
- methylphenidate: 1.2%
- methylprednisolone
- methysergide
- metipranolol
- metolazone
- metoprolol
- metronidazole
- mexiletine: 1.9% - 7.7%
- mianserin
- midazolam
- midodrine
- mifepristone
- miglustat: common, 0% - 17%
- mirtazapine: postmarketing, 7.51% - 8%
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone: 0% - 24%
- moclobemide
- modafinil
- montelukast: postmarketing, 1.8%
- morphine: postmarketing, 2%
- moxifloxacin
- moxonidine: postmarketing
- mycophenolate mofetil: 1.8% - 43.3%
- mycophenolic acid: postmarketing, 33.8% - 43.3%
- nabilone: 7.6%
- nabumetone: 0.7%
- nalbuphine
- nalidixic acid
- nalmefene
- naloxone
- naltrexone: postmarketing
- naphazoline
- naproxen: 1% - 1-3%
- nateglinide
- nebivolol
- nefazodone: 1.3%
- nelarabine: 0% - 17%
- nelfinavir
- neostigmine: postmarketing
- niacin: postmarketing
- nicardipine: 0.7% - 4.4%
- nicorandil: common
- nicotine
- nifedipine: 2% - 12%
- nilotinib: common, 0% - 9%
- nilutamide
- nitazoxanide
- nitrazepam
- nitrite
- nitrofurantoin
- nitroglycerin
- nizatidine: 1.9% - 3.1%
- norfloxacin: postmarketing, 1.3%
- nortriptyline
- ofatumumab: 0% - 5%
- ofloxacin: postmarketing
- olanzapine: common, 2% - 27%
- olmesartan: postmarketing, uncommon
- olmesartan medoxomil
- olopatadine
- omeprazole: 1.3%
- ondansetron
- orlistat: common
- orphenadrine
- oxaliplatin: very common, 1% - 23.4%
- oxaprozin
- oxcarbazepine: common, 2% - 7%
- oxybutynin: 1.7% - 2.5%
- oxycodone: 6% - 7%
- oxymorphone
- paclitaxel: postmarketing, rare, common, very common, 1% - 47%
- paliperidone: common, 0% - 4%
- palonosetron
- pamidronate: 16.1% - 25.6%
- pantoprazole: postmarketing
- parecoxib
- paricalcitol
- paroxetine: common, 0% - 18%
- pazopanib: 0% - 14%
- penbutolol: 0.4% - 4.9%
- penicillin
- pentazocine
- pentostatin: 10% - 13%
- pentoxifylline
- perampanel: 1% - 2%
- pergolide: frequent, 4.2%
- perhexiline
- perindopril: 7.9%
- perindopril erbumine: 6.6% - 8.7%
- perindoprilat
- phenelzine
- phentolamine: postmarketing, common
- phenytoin: 0% - 3.9%
- phosphate
- pilocarpine: 2% - 12%
- pimozide: 13.9% - 25%
- pindolol: 1% - 4%
- pioglitazone: 4.1%
- pirbuterol: 0% - 1.3%
- pirfenidone
- piroxicam
- pitavastatin: postmarketing
- pixantrone
- pizotifen
- polythiazide
- pomalidomide: 11.2% - 62.5%
- ponatinib: 3% - 39%
- posaconazole: 1.62% - 13%
- potassium
- potassium phosphate
- pralatrexate
- pramipexole: 1% - 14%
- pravastatin: postmarketing, 0.5%
- praziquantel: postmarketing
- prazosin: 7%
- prednisolone phosphate
- prednisone
- pregabalin: 2% - 12.6%
- prilocaine
- procainamide
- procarbazine
- progesterone
- propafenone: postmarketing, 0.6% - 4.41%
- propantheline
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol: postmarketing
- prostacyclin
- protriptyline
- pyridostigmine
- quetiapine: 1% - 17.6%
- quinidine: 2% - 13%
- rabeprazole
- raltegravir
- raltitrexed: 29-42%
- ramipril: 2% - 3.7%
- ramiprilat: 2%
- ranolazine
- rapamycin: 22% - 40%
- rasagiline: frequent
- reboxetine
- regadenoson: common
- regorafenib
- retigabine: 4% - 6%
- retinoic acid: postmarketing
- ribavirin: very common, 5% - 68%
- rifabutin: 1%
- rifapentine
- rifaximin
- riluzole: 14.8% - 20.1%
- rimantadine: 0.5% - 1.4%
- rimonabant
- risedronate: 0% - 5.4%
- risperidone: frequent, 0% - 4%
- ritonavir: 9.4% - 28.4%
- rivaroxaban
- rivastigmine: common, 0% - 6%
- rizatriptan: 4% - 7%
- rofecoxib: 1% - 2.6%
- roflumilast
- ropinirole: frequent, 5% - 16%
- ropivacaine
- rosuvastatin: common, 0.9% - 4.7%
- rotigotine: 4%
- salbutamol: 1% - 3%
- saquinavir: common
- sertraline: postmarketing, common, frequent
- sevoflurane
- sibutramine
- sildenafil
- silodosin
- simvastatin: postmarketing, 0.9% - 1.6%
- sodium
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate: 7%
- sofosbuvir: common, 3% - 21%
- sorafenib: postmarketing, very common, 0% - 6%
- sotalol: 1% - 13%
- sparfloxacin: 1.7%
- stavudine: very rare, postmarketing, uncommon
- sulfamethoxazole
- sulindac
- sumatriptan: common, 0.4% - 5%
- sunitinib: 5%
- tacrolimus: 0% - 52%
- tadalafil
- tamoxifen: 1.07% - 18.6%
- tamsulosin: postmarketing, uncommon, 0.7% - 8.54%
- tapentadol: 2%
- technetium-99m
- telavancin: uncommon
- telithromycin
- telmisartan: postmarketing, rare, uncommon
- temazepam: 0.9% - 1.4%
- temozolomide: uncommon, common, 1.05% - 12.7%
- temsirolimus
- teniposide
- tenofovir: postmarketing, 7% - 11%
- tenofovir disoproxil fumarate: postmarketing, very common, 7% - 11%
- terazosin: 1.6% - 11.3%
- terbutaline: 0.5% - 2.6%
- terconazole: postmarketing
- testosterone: postmarketing, 0% - 3%
- testosterone undecanoate
- tetrabenazine
- tetraen
- tetrahydrozoline
- tetrofosmin
- thalidomide: 2.9% - 23.9%
- thiabendazole
- thiamine
- thiazide
- thiotepa: 1-10%
- thiothixene
- tiagabine: 1.1% - 23%
- tiaprofenic acid
- ticlopidine
- tigecycline: 1.7% - 3%
- tiludronate
- timolol: postmarketing, 1% - 5%
- tinidazole: 1.1% - 2.1%
- tiopronin
- tipranavir
- tizanidine: postmarketing, 41% - 78%
- tobramycin: 35.7%
- tolazamide
- tolcapone
- tolmetin
- tolvaptan: common, 8.52%
- topiramate: very rare, postmarketing, 0% - 8%
- topotecan: very common, 0% - 25%
- torasemide: 2%
- toremifene
- trabectedin
- tramadol: rare, common, 0.744% - 12%
- trametinib
- trandolapril: 2.01% - 3.3%
- trandolaprilat: 3.3%
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- travoprost: rare, uncommon
- trazodone: postmarketing
- treprostinil
- triamterene
- triazolam
- trien
- trihexyphenidyl
- trimipramine
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valganciclovir: 4% - 6%
- valproate: postmarketing, 0% - 27%
- valrubicin
- valsartan: uncommon
- vandetanib: 0.4% - 14.7%
- vardenafil
- varenicline: uncommon, 4% - 7%
- vemurafenib: postmarketing, 0% - 11%
- venlafaxine: common, 1% - 19%
- verapamil: postmarketing, 2%
- verteporfin: common
- vigabatrin: 5% - 7%
- vildagliptin: uncommon, common
- vinblastine
- vincristine: 4.82%
- vinflunine
- vinorelbine: 0% - 36%
- vismodegib
- vitamin D2
- voriconazole: common
- vorinostat
- warfarin
- zafirlukast: 1.8%
- zalcitabine
- zaleplon: uncommon, 5% - 7%
- ziconotide: 13% - 18%
- zidovudine: uncommon, 8.6% - 9%
- zidovudine/lamivudine
- ziprasidone: 0% - 6%
- zoledronic acid: postmarketing, uncommon, common, 1% - 6.1%
- zolmitriptan: rare, 3% - 11%
- zolpidem: frequent, 1%
- zonisamide: frequent
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|